G9962 Embolization endpoints are documented separately for each embolized vessel and ovarian artery angiography or embolization performed in the presence of variant uterine artery anatomy
Billable / valid for submission HCPCS Release 2026Q3
Short description: Embolization doc separatly
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| 2026Q3 | 2026-07-01 | current | Embolization endpoints are documented separately for each embolized vessel and ovarian artery angiography or embolization performed in the presence of variant uterine artery anatomy | yes |
Related codes in G99
- G9900 Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results were not documented and reviewed, reason not otherwise specified
- G9901 Patient age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54, or 56 for more than 90 consecutive days during the measurement period
- G9902 Patient screened for tobacco use and identified as a tobacco user
- G9903 Patient screened for tobacco use and identified as a tobacco non-user
- G9905 Patient not screened for tobacco use
- G9906 Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy)
- G9908 Patient identified as tobacco user did not receive tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy)
- G9910 Patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 consecutive days during the measurement period
- G9911 Clinically node negative (t1n0m0 or t2n0m0) invasive breast cancer before or after neoadjuvant systemic therapy
- G9912 Hepatitis b virus (hbv) status assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy
- G9913 Hepatitis b virus (hbv) status not assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy, reason not otherwise specified
- G9914 Patient initiated an anti-tnf agent
- G9915 No record of hbv results documented
- G9916 Functional status performed once in the last 12 months
- G9917 Documentation of advanced stage dementia and caregiver knowledge is limited
- G9918 Functional status not performed, reason not otherwise specified
- G9919 Screening performed and positive and provision of recommendations
- G9920 Screening performed and negative
- G9922 Safety concerns screen provided and if positive then documented mitigation recommendations
- G9923 Safety concerns screen provided and negative